Fifty years of thiazide diuretic therapy for hypertension

Archives of Internal Medicine

Volumn 169, Issue 20, 2009, Pages 1851-1856

  Moser, Marvin ^a   Feig, Peter U ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLOROTHIAZIDE; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOOP DIURETIC AGENT; RESERPINE; SULFONAMIDE; THIAZIDE DIURETIC AGENT;

ADJUVANT THERAPY; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG PREFERENCE; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SECONDARY PREVENTION; SEXUAL DYSFUNCTION; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SODIUM CHLORIDE SYMPORTER INHIBITORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70449671207     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.342     Document Type: Review

References (46)

1. Freis ED, Wanko A, Wilson IM, et al. Treatment of essential hypertension with chlorothiazide (Diuril). JAMA. 1958;166(2):137-140.
2. Moser M, Macauley AI. Chlorothiazide as an adjunct in the treatment of essential hypertension. Am J Cardiol. 1959;3(2):214-219.
3. Southworth H. Acidosis associated with the administration of para-amino-benzene-sulfonamide (Prontylin). Proc Soc Exp Biol Med. 1937; 36:58-61.
4. Strauss MB, Southworth H. Urinary changes due to sulfonamide administration. Bull Johns Hopkins Hosp. 1938;63:41-45.
5. Pitts RF, Alexander RS. The nature of the renal tubular mechanism for acidifying the urine. Am J Physiol. 1945;144(2):239-254.
6. Novello FC, Sprague JM. Benzothiadiazine dioxides as novel diuretics. J Am Chem Soc. 1957; 79(8):2028-2029.
7. Beyer KH Jr, Baer JE, Russo HF, Noll R. Electrolyte excretion as influenced by chlorothiazide. Science. 1958;127(3290):146-147.
8. Tarazi RC, Dustan HP, Frohlich ED. Long term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation. 1970;41(4):709-717.
9. Tobian L Jr, Binion JT. Tissue cation and water in arterial hypertension. Circulation. 1952;5(5): 754-758.
10. Sica DA, Moser M. Diuretic therapy in cardiovascular disease. In: Black HR, Elliott WJ, eds. Hypertension: A Companion to Braunwald's Heart Disease. Philadelphia, PA:WBSaunders Co; 2007.
11. Veterans Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202(11):1028-1034.
12. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, I: reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242(23):2562-2571. (Pubitemid 10170285)
13. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA. 1982; 248(12):1465-1477.
14. Moser M. Clinical trials and their effect on medical therapy: the Multiple Risk Factor Intervention Trial. Am Heart J. 1984;107(3):616-618.
15. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993; 153(5):578-581. (Pubitemid 23072387)
16. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24): 3255-3264.
17. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age and older. N Engl J Med. 2008;358(18):1887-1898.
18. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155(8): 829-837.
19. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288(23):2981-2997.
20. Moser M. Results of ALLHAT: is this the final answer regarding initial antihypertensive drug therapy? Arch Intern Med. 2003;163(11):1269-1273. (Pubitemid 36676191)
21. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289 (19):2560-2572. (Pubitemid 37430158)
22. Ernst ME, Carter BL, Goerdt CJ, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47(3):352-358. (Pubitemid 43740274)
23. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability Hypertension. 2004; 43(1):4-9.
24. Ernst ME, Carter BL, Basile JN. All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective J Clin Hypertens (Greenwich). 2009;11(1):5-10.
25. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356(9246):1955-1964.
26. Turnbull F, Neal B, Ninomiya T, et al; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. BMJ. 2008;336(7653):1121-1123.
27. Houston MC. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J. 1989;117(4):911-951.
28. Moser M. Suppositions and speculations - their possible effects on treatment decisions in the management of hypertension. Am Heart J. 1989; 118(6):1362-1369. (Pubitemid 20014692)
29. McInnes GT, Yeo WW, Ramsay LE, Moser M. Cardiotoxicity and diuretics: much speculation, little substance. J Hypertens. 1992;10(4):317-335.
30. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med. 1995; 122(3):223-226.
31. Moser M, Blaufox MD, Freis E, et al. Who really determines your patients' prescriptions? JAMA. 1991;265(4):498-500.
32. Dahlöf B, Devereux RB, Kjeldsen SE, et al; LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002; 359(9311):995-1003. (Pubitemid 34286536)
33. Moser M, Pickering TG, Weber MA. Blood pressure lowering by any means, or do specific medications make a difference? J Clin Hypertens (Greenwich). 2001;3(6):369-375.
34. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358(9287):1033-1041. (Pubitemid 32925123)
35. Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23): 2417-2428.
36. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-713.
37. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359(15):1565-1576.
38. Moser M. Diuretics revisited - again. J Clin Hypertens (Greenwich). 2001;3(3):136-138.
39. Finnerty FA Jr, Maxwell MH, Lunn J, Moser M. Long-term effects of furosemide and hydrochlorothiazide in patients with essential hypertension: a two-year comparison of efficacy and safety. Angiology. 1977;28(2):125-133. (Pubitemid 8065265)
40. Shafi T, Appel LJ, Miller ER III, Klag MJ, Parekh RS. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension. 2008;52(6): 1022-1029.
41. Barzilay JI, Davis BR, Cutler JA, et al; ALLHAT Collaborative Research Group. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med. 2006;166(20):2191-2201.
42. Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR; SHEP Collaborative Research Group. Long-term effect of diuretic- based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol. 2005;95(1):29-35.
43. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104 (4):545-556.
44. Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension. 2001;37 (6):1458-1464. (Pubitemid 34225392)
45. Jeck N, Schlingmann KP, Reinalter SC, et al. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol. 2005;288(4):R782-R795. (Pubitemid 40404149)
46. Rossier BC, Schild L. Epithelial sodium channel: mendelian versus essential hypertension. Hypertension. 2008;52(4):595-600.